More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Press Releases
    • Media Coverage
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Press Releases
    • Media Coverage

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Bolsters IP Portfolio with Multiple Patents Issued in 12 Key European Territories

by Kyle Porter | Jul 9, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, July 09, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived...

Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors

by Kyle Porter | Jun 4, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, June 4, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™

by Kim Nunley | Apr 9, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, April 9, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders

by Kim Nunley | Mar 19, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, March 19, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in the European Union (EU)

by Kim Nunley | Mar 5, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, March 5, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Strengthens Intellectual Property Portfolio with New Chinese-Issued Patent

by Kim Nunley | Feb 20, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, Feb. 20, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...
« Older Entries

POPULAR

  • Medical Marijuana Inc.’s & Dixie Elixir’s Tripp Keber, to Appear on Sirius XM Radio’s iCannabis Channel Tonight Dixie Botanicals
  • Medical Marijuana Inc. Applauds Victories for Veterans, Lone Star State CanChew Biotechnologies Dixie Botanicals Hempmeds Medical Marijuana Inc.
  • PhytoSPHERE Systems, a Medical Marijuana Inc Portfolio Company, to Bring Production Facilities to Europe through Canipa Holdings CanChew Dixie Botanicals phytosphere systems Red Dice Holdings
  • HempMeds®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line with Two New Flavors
  • Forbes Features Medical Marijuana, Inc. in Article Citing Company’s Sales Data After Starting CBD Market ‘That Could Grow 700% by 2020’ AXIM Biotechnologies Dixie Botanicals Kannaway Medical Marijuana Inc. Real Scientific Hemp Oil

LAST NEWS

  • Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as 2020 CEO World Award Winners
  • Medical Marijuana Inc. Announces National Marketing Campaign with WeedMaps
  • [Listen] Kannalife Sciences CEO Dean Petkanas and Medical Marijuana Inc. CEO Stuart Titus Announce #TreatCTE Awareness Campaign on San Diego Union Tribune Radio
  • Medical Marijuana, Inc. Portfolio Company Kannalife Featured in Sports Illustrated Article about Research That Could Be “Future New Wave of Medicine”
  • Medical Marijuana, Inc. Appoints New Chief Financial Officer

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.